Carson Wealth (CWM LLC)
PMCB icon

Carson Wealth (CWM LLC)’s PharmaCyte Biotech PMCB Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio PMCB Stock Details PMCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Hold
1
– – ﹤0.01% 5669
2025
Q4 		$0 Hold
1
– – ﹤0.01% 5577
2025
Q3 		$0 Hold
1
– – ﹤0.01% 5475
2025
Q2 		$0 Hold
1
– – ﹤0.01% 5258
2025
Q1 		$0 Hold
1
– – ﹤0.01% 5161
2024
Q4 		$0 Hold
1
– – ﹤0.01% 5097
2024
Q3 		$0 Hold
1
– – ﹤0.01% 5073
2024
Q2 		$0 Sell
1
-953
-100% -$2.05K ﹤0.01% 4861
2024
Q1 		$2K Hold
954
– – ﹤0.01% 4024
2023
Q4 		$2K Hold
954
– – ﹤0.01% 3832
2023
Q3 		$2K Hold
954
– – ﹤0.01% 3848
2023
Q2 		$3K Buy
954
+953
+95,300% +$2.86K ﹤0.01% 3681
2023
Q1 		$0 Hold
1
– – ﹤0.01% 4279
2022
Q4 		$0 Hold
1
– – ﹤0.01% 4183
2022
Q3 		$0 Hold
1
– – ﹤0.01% 4123
2022
Q2 		$0 Buy
+1
New +$2 ﹤0.01% 4033
2022
Q1 		– Sell
-1
Closed – – 3798
2021
Q4 		$0 Buy
+1
New +$3 ﹤0.01% 3614

Other funds holding PMCB

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Carson Wealth (CWM LLC)'s PMCB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its PharmaCyte Biotech (PMCB) position steady in Q1 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5669.

Carson Wealth (CWM LLC) first reported a position in PMCB in Q4 2021 and has held it in 17 quarters since. The position peaked at $3K in Q2 2023. 32 funds tracked by Wall St. Rank hold PMCB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 1 share of PharmaCyte Biotech worth $1 as of Q1 2026.
  • Carson Wealth (CWM LLC) left its PharmaCyte Biotech share count unchanged in Q1 2026.
  • PharmaCyte Biotech made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5669 holding.
  • Carson Wealth (CWM LLC) first reported a position in PharmaCyte Biotech in Q4 2021 and has held it in 17 quarters since.
  • Carson Wealth (CWM LLC)'s PharmaCyte Biotech position peaked at $3K in Q2 2023.
  • 32 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.